HIGHLIGHTS
- who: Jingli Du and colleagues from the University of Erlangen Nuremberg, Germany have published the research work: Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19, in the Journal: (JOURNAL) of 13/01/2023
- what: (4) the immunogenicity of BCG was not affected even in patients with LTBI Randomized, three-arm, placebo-controlled, partially-blinded clinical trial aimed to enroll 990 healthy, HIV-uninfected, QFT-negative, 12- to 17-year-old adolescents, BCG- vaccinated in infancy
- how: A previous study assessed the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.